Literature DB >> 17702633

Evaluation of the Dutch version of the Parkinson's Disease Questionnaire 39.

Johan Marinus1, Martine Visser, Crispin Jenkinson, Anne M Stiggelbout.   

Abstract

The psychometric properties of the Dutch version of the Parkinson's disease questionnaire 39 (PDQ39-DV) were tested in 177 patients with Parkinson's disease (PD). Internal consistency of 7 of the 8 scales was adequate (>or=0.70), but was insufficient for 'bodily discomfort' (0.59). Correlation between the PDQ39 and other instruments in this study, the SCOPA-psychosocial questionnaire, Euroqol-5D, hospital anxiety and depression scale, and a visual analogue scale for quality of life, were 0.82, 0.74, 0.63 and -0.54, respectively. The factor analysis yielded 8 factors, which accounted for 65% of the variance and revealed only small differences with the original UK version. We conclude that the PDQ39-DV displays satisfactory psychometric properties and is an appropriate instrument to assess quality of life in Dutch patients with PD.

Entities:  

Mesh:

Year:  2007        PMID: 17702633     DOI: 10.1016/j.parkreldis.2007.05.005

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  8 in total

1.  Quality of life in Serbian patients with Parkinson's disease.

Authors:  Ljubomir Ziropada; Elka Stefanova; Aleksandra Potrebić; Vladimir S Kostić
Journal:  Qual Life Res       Date:  2009-06-27       Impact factor: 4.147

2.  Validity and reliability testing of the Chinese (mainland) version of the 39-item Parkinson's Disease Questionnaire (PDQ-39).

Authors:  Wei Luo; Xiao-hong Gui; Bo Wang; Wen-ying Zhang; Zhi-yuan Ouyang; Yi Guo; Bao-rong Zhang; Mei-ping Ding
Journal:  J Zhejiang Univ Sci B       Date:  2010-07       Impact factor: 3.066

3.  Quality of life in patients with Parkinson's disease: Translation and psychometric evaluation of the Iranian version of PDQ-39.

Authors:  Marzieh Nojomi; Zahra Mostafavian; Gholam Ali Shahidi; Crispin Jenkinson
Journal:  J Res Med Sci       Date:  2010-03       Impact factor: 1.852

4.  Transitions in Parkinson's disease in primary care: protocol of a longitudinal mixed methods study.

Authors:  Annette O A Plouvier; Tim C Olde Hartman; Chris van Weel; Bastiaan R Bloem; Antoine L M Lagro-Janssen
Journal:  BMJ Open       Date:  2015-06-02       Impact factor: 2.692

5.  Acupuncture Effect and Mechanism for Treating Pain in Patients With Parkinson's Disease.

Authors:  Shao-Wen Yu; Sung-Han Lin; Chih-Chien Tsai; Kallol Ray Chaudhuri; Yu-Chieh Huang; Yu-Sheng Chen; Bo-Yan Yeh; Yih-Ru Wu; Jiun-Jie Wang
Journal:  Front Neurol       Date:  2019-10-22       Impact factor: 4.003

6.  Effectiveness of occupational therapy in Parkinson's disease: study protocol for a randomized controlled trial.

Authors:  Ingrid H W M Sturkenboom; Maud J Graff; George F Borm; Eddy M M Adang; Maria W G Nijhuis-van der Sanden; Bastiaan R Bloem; Marten Munneke
Journal:  Trials       Date:  2013-02-02       Impact factor: 2.279

7.  Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson's disease: the LEAP-study.

Authors:  Constant V M Verschuur; S R Suwijn; B Post; M Dijkgraaf; B R Bloem; J J van Hilten; T van Laar; G Tissingh; G Deuschl; A E Lang; R J de Haan; R M A de Bie
Journal:  BMC Neurol       Date:  2015-11-19       Impact factor: 2.474

8.  General Anesthesia versus Local Anesthesia in StereotaXY (GALAXY) for Parkinson's disease: study protocol for a randomized controlled trial.

Authors:  R A Holewijn; D Verbaan; R M A de Bie; P R Schuurman
Journal:  Trials       Date:  2017-09-07       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.